What it sells
NeuroXess develops implantable flexible brain-computer interface systems, from chips to algorithms, to help patients with ALS, high paraplegia and stroke restore motor and language function.
Business model breakdown
Distribution: how it reaches customers
Clinical inquiries and product trial application forms on site
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-10-28 | Series B | CNY 700M | 国投聚力 (lead), 深创投 (lead), 勤智资本 (lead) | news.google.com |
| 2026-10-28 | — | CNY 700M | — | news.google.com |
| 2026-10-28 | Series B | RMB 700M | — | news.google.com |
| 2026-10-28 | Series B | RMB 700M | — | news.google.com |
| 2026-10-28 | Series B | CNY 700M | — | 36kr.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-29.